These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 89652

  • 41. [Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker].
    Ruibal A, Guarga A, Encabo G, Urrutia A.
    Med Clin (Barc); 1985 Nov 16; 85(16):687-8. PubMed ID: 2417068
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [A long term follow-up study in patients with chronic liver diseases with special reference to serum alpha-fetoprotein].
    Ohtsuyama Y.
    Nihon Shokakibyo Gakkai Zasshi; 1982 Oct 16; 79(10):1962-9. PubMed ID: 6185707
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Radioimmunoassay determination of alpha fetoprotein. Rapid method].
    Kanao K, Ishihara S, Honda M, Ogawa T, Yagi E.
    Radioisotopes; 1978 Jan 16; 27(1):46-9. PubMed ID: 76324
    [No Abstract] [Full Text] [Related]

  • 46. Elevated alpha-fetoprotein in association with loss of serum HBeAg.
    McDonnell WM, Lucey MR.
    Am J Gastroenterol; 1993 Sep 16; 88(9):1441-3. PubMed ID: 7689785
    [No Abstract] [Full Text] [Related]

  • 47. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
    Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, Lee CS, Wei TC.
    Gastroenterology; 1984 Jun 16; 86(6):1404-9. PubMed ID: 6201411
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Alphafetoprotein in liver disease.
    Ahmed W, Lodi TZ, Zuberi SJ.
    J Pak Med Assoc; 1988 Sep 16; 38(9):234-6. PubMed ID: 2467997
    [No Abstract] [Full Text] [Related]

  • 53. Value of serum protective activity against acid precipitation of poly (U) in the differentiation between cirrhotic patients with and without hepatocellular carcinoma.
    Kouretas D, Kountouras J, Tsapas G, Anastasiades N, Tsakiri I, Antonoglou O.
    Anticancer Res; 1990 Sep 16; 10(4):1025-8. PubMed ID: 1696444
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Stromal-predominant mesenchymal hamartoma of the liver with elevated serum alpha-fetoprotein level.
    Gunes D, Uysal KM, Cecen E, Cakmakci H, Ozer E, Akgur FM, Olgun N.
    Pediatr Hematol Oncol; 2008 Sep 16; 25(7):685-92. PubMed ID: 18850482
    [Abstract] [Full Text] [Related]

  • 57. [A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases].
    Cioffi M, Fratta M, De Lucia D, Bresciani F.
    Arch Monaldi Mal Torace; 1990 Sep 16; 45(3):159-65. PubMed ID: 1726999
    [Abstract] [Full Text] [Related]

  • 58. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J, Zichová M, Vodák M.
    Sb Lek; 1993 Sep 16; 94(4):311-5. PubMed ID: 7527585
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Measurement of alpha-fetoprotein by radioimmunometric assay using plastic bead as a solid phase (author's transl)].
    Iio A, Wada M, Ata M, Ito H, Koizumi M, Ishine M, Inatsuki S, Hamamoto K.
    Kaku Igaku; 1982 Mar 16; 19(2):323-9. PubMed ID: 6180195
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.